DocSym
β
Searchsearch
Search
(L57.3) Poikiloderma of civatte
More details coming soon
60 840 in individuals diagnosis poikiloderma of civatte confirmed
633 deaths with diagnosis poikiloderma of civatte
1% mortality rate associated with the disease poikiloderma of civatte
Diagnosis poikiloderma of civatte is diagnosed Women are 38.25% more likely than Men
18 784
Men receive the diagnosis poikiloderma of civatte
321 (1.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
42 056
Women receive the diagnosis poikiloderma of civatte
312 (0.7 %)Died from this diagnosis.
Risk Group for the Disease poikiloderma of civatte - Men aged 70-74 and Women aged 60-64
In Men diagnosis is most often set at age 5-9, 15-19, 25-39, 45-94
Less common in men the disease occurs at Age 0-5, 10-14, 20-24, 40-44, 95+Less common in women the disease occurs at Age 0-19
In Women diagnosis is most often set at age 0-1, 20-95+
Disease Features poikiloderma of civatte
Absence or low individual and public risk
Poikiloderma of civatte - what does this mean
Poikiloderma of civatte is a condition that affects the skin on the neck and chest, resulting in a mottled appearance of redness, discoloration, and thinning of the skin. it is caused by chronic sun exposure and is more common in fair-skinned individuals.
What happens during the disease - poikiloderma of civatte
Poikiloderma of civatte is a skin condition that is caused by chronic sun exposure. it is characterized by a combination of hyperpigmentation and hypopigmentation, along with telangiectasias, scaling, and atrophy of the skin. the underlying pathogenesis is believed to be due to the accumulation of reactive oxygen species in the skin caused by the uv exposure, which leads to the breakdown of collagen and elastin, resulting in the characteristic changes seen in poikiloderma of civatte.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the affected area
- Skin biopsy
- Blood tests
- Imaging tests such as X-rays or CT scans
- Tissue culture
- Patch testing
- Photopatch testing
Treatment and Medical Assistance
Main goal: To reduce skin discoloration, improve skin texture, and reduce inflammation associated with Poikiloderma of Civatte.
- Sun protection: Wearing a broad-spectrum sunscreen with an SPF of 30 or higher and avoiding direct sun exposure.
- Topical treatments: Applying creams containing retinoids, hydroquinone, and corticosteroids.
- Chemical peels: Using chemical peels to remove the top layer of skin, revealing smoother skin beneath.
- Laser treatments: Using laser treatments to reduce the appearance of redness and discoloration.
- Photodynamic therapy: Using light-activated drugs to improve skin texture and reduce inflammation.
- Cryotherapy: Using freezing temperatures to reduce inflammation and improve skin texture.
7 Days of Hospitalization Required
33 Hours Required for Outpatient Treatment
Poikiloderma of civatte - Prevention
Poikiloderma of civatte can be prevented by avoiding excessive sun exposure, using a broad-spectrum sunscreen with an spf of 30 or higher, wearing protective clothing such as long-sleeved shirts and wide-brimmed hats, and avoiding the use of tanning beds.